Jones Trading Initiates Coverage On Enliven Therapeutics with Buy Rating, Announces Price Target of $36
11 Good Energy, Inc. -0.14%
11 Good Energy, Inc. ELVN | 28.96 | -0.14% |
Jones Trading analyst Soumit Roy initiates coverage on Enliven Therapeutics (NASDAQ:
ELVN) with a Buy rating and announces Price Target of $36.